These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Mucolytics in acute and chronic respiratory tract disorders. II. Uses for treatment and antioxidant properties]. Kupczyk M; Kuna P Pol Merkur Lekarski; 2002 Mar; 12(69):248-52. PubMed ID: 12053601 [TBL] [Abstract][Full Text] [Related]
4. Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease. Teo E; House H; Lockhart K; Purchuri SN; Pushparajah J; Cripps AW; van Driel ML Cochrane Database Syst Rev; 2014 Sep; (9):CD010010. PubMed ID: 25201571 [TBL] [Abstract][Full Text] [Related]
5. [Antioxidative features of ambroxol--usefulness in COPD]. Nowak D Pneumonol Alergol Pol; 2001; 69(9-10):590-3. PubMed ID: 11928667 [No Abstract] [Full Text] [Related]
6. Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: systematic review. Poole PJ; Black PN BMJ; 2001 May; 322(7297):1271-4. PubMed ID: 11375228 [TBL] [Abstract][Full Text] [Related]
7. The role of N-acetylcysteine in the treatment of chronic obstructive pulmonary disease. van Herwaarden CL; Bast A; Dekhuijzen PN Neth J Med; 1995 Aug; 47(2):45-8. PubMed ID: 7566280 [No Abstract] [Full Text] [Related]
8. Impact of Mucolytic Agents on COPD Exacerbations: A Pair-wise and Network Meta-analysis. Cazzola M; Rogliani P; Calzetta L; Hanania NA; Matera MG COPD; 2017 Oct; 14(5):552-563. PubMed ID: 28753070 [TBL] [Abstract][Full Text] [Related]
9. Oxidation pathway and exacerbations in COPD: the role of NAC. Matera MG; Calzetta L; Cazzola M Expert Rev Respir Med; 2016; 10(1):89-97. PubMed ID: 26567752 [TBL] [Abstract][Full Text] [Related]
10. Acute exacerbations of chronic bronchitis: focusing management for optimum results. Aboussouan LS Postgrad Med; 1996 Apr; 99(4):89-90, 95-8, 101-2. PubMed ID: 8604417 [TBL] [Abstract][Full Text] [Related]
11. A controlled trial of ambroxol in chronic bronchitis. Guyatt GH; Townsend M; Kazim F; Newhouse MT Chest; 1987 Oct; 92(4):618-20. PubMed ID: 3308343 [TBL] [Abstract][Full Text] [Related]
12. [A controlled study on the action of a new formulation of ambroxol in asthmatiform bronchitis in children]. Baldini G; Gucci M; Tarò D; Memmini C Minerva Pediatr; 1989 Feb; 41(2):91-5. PubMed ID: 2661989 [TBL] [Abstract][Full Text] [Related]
13. Effect of twelve-months therapy with oral ambroxol in preventing exacerbations in patients with COPD. Double-blind, randomized, multicenter, placebo-controlled study (the AMETHIST Trial). Malerba M; Ponticiello A; Radaeli A; Bensi G; Grassi V Pulm Pharmacol Ther; 2004; 17(1):27-34. PubMed ID: 14643168 [TBL] [Abstract][Full Text] [Related]
14. Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease. Poole PJ; Black PN Cochrane Database Syst Rev; 2000; (2):CD001287. PubMed ID: 10796634 [TBL] [Abstract][Full Text] [Related]
15. [N-acetylcystein in the therapy of chronic bronchitis]. Reichenberger F; Tamm M Pneumologie; 2002 Dec; 56(12):793-7. PubMed ID: 12486618 [TBL] [Abstract][Full Text] [Related]
17. Mucolytic and antibiotic effect of a new compound in chronic bronchitis. Bŭrgi H Chemotherapy; 1975; 21(3-4):167-74. PubMed ID: 1098866 [TBL] [Abstract][Full Text] [Related]
18. Intraluminal inflammation in the airways of patients with chronic bronchitis after treatment with Ambroxol. Lusuardi M; Capelli A; Salmona M; Tacconi MT; Cerutti CG; Donner CF Monaldi Arch Chest Dis; 1995 Oct; 50(5):346-51. PubMed ID: 8541815 [TBL] [Abstract][Full Text] [Related]